Prediction: Lilly Will Trade at Record High in 12 Months
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
This quick comparison explains why price indices and total return indices diverge, focusing on dividends and reinvestment effects.
28,657 articlesEli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Peter Thiel and Founders Fund have fully exited ETHZilla, dissolving a high-profile treasury bet linked to Ethereum. ...
Newmont released after-hours results, signaling steady production yet revenue depends on gold prices. The company gui...
Ultra-prime Manhattan sales are accelerating even as policy debates intensify. Brokers say buyers and sellers remain ...
Corcoran Reverie announces an exclusive tie-up with Housify Form to provide its agents with advanced valuation and ma...
Two tobacco giants show divergent paths over 10 years, with dividend income boosting returns for both. Here's what ha...
Intel posted a stronger-than-expected Q1, yet rising costs and cash-flow strain raise the risk of a sharper pullback....
Wells Fargo trades near $79 as investors priced in about 16% upside over the next year, driven by regulatory relief, ...
Three under-the-radar high-yield ETFs are delivering higher income in a market where cash yields rise. This report br...
Tensions with Iran push costs beyond official tallies, raising inflation risk and weighing on markets. This report br...
iQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
Bitcoin stabilizes after a volatile week, signaling a potential turn for BTC as investors eye SpaceX's blockbuster IP...